These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Measurement of gold treatment effect in clinical practice: evidence for effectiveness of intramuscular gold therapy. Wolfe F, Hawley DJ, Cathey MA. J Rheumatol; 1993 May; 20(5):797-802. PubMed ID: 8336305 [Abstract] [Full Text] [Related]
23. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, Cohen S, Felson D. Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413 [Abstract] [Full Text] [Related]
24. [A multicenter cross-sectional study on the Health Related Quality of Life of patients with rheumatoid arthritis using a revised Japanese version of the Arthritis Impact Measurement Scales Version 2 (AIMS 2), focusing on physical disability and its associative factors]. Hashimoto A, Sato H, Nishibayahi Y, Shiino Y, Kutsuna T, Ishihara Y, Hoshi K, Fujimori J, Tsuboi S, Kondo H, Akizuki M, Moroi Y, Yoshida S. Ryumachi; 2001 Feb; 41(1):9-24. PubMed ID: 11296456 [Abstract] [Full Text] [Related]
25. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists. Verburg RJ, Mahabali SD, Stiggelbout AM, Sont JK, van Laar JM. J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724 [Abstract] [Full Text] [Related]
26. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. Fries JF, Ramey DR. J Rheumatol; 1997 Sep; 24(9):1697-702. PubMed ID: 9292790 [Abstract] [Full Text] [Related]
27. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. Clarke AE, St-Pierre Y, Joseph L, Penrod J, Sibley JT, Haga M, Genant HK. J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412 [Abstract] [Full Text] [Related]
28. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission. Sokka T, Pincus T. J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382 [Abstract] [Full Text] [Related]
29. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. James D, Young A, Kulinskaya E, Knight E, Thompson W, Ollier W, Dixey J, Early Rheumatoid Arthritis Study Group (ERAS), UK. Rheumatology (Oxford); 2004 Mar; 43(3):369-76. PubMed ID: 14722346 [Abstract] [Full Text] [Related]
34. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. Ward MM. J Rheumatol; 1997 Jan; 24(1):35-42. PubMed ID: 9002008 [Abstract] [Full Text] [Related]
35. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcón GS, Trentham DE, Neuner R, Clegg DO, Leisen JC, Heyse SP. J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931 [Abstract] [Full Text] [Related]
36. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Small R, Wolfe F. J Rheumatol; 1991 Mar; 18(3):334-8. PubMed ID: 1856803 [Abstract] [Full Text] [Related]
38. Self-assessment of disease activity by patients with rheumatoid arthritis. Hanly JG, Mosher D, Sutton E, Weerasinghe S, Theriault D. J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920 [Abstract] [Full Text] [Related]
39. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy. Capell H, McCarey D, Madhok R, Hampson R. J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318 [Abstract] [Full Text] [Related]
40. Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health. Kievit W, Welsing PM, Adang EM, Eijsbouts AM, Krabbe PF, van Riel PL. Arthritis Rheum; 2006 Oct 15; 55(5):745-50. PubMed ID: 17013821 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]